Screening compound: C13H10BrClN2O2 (3617-1251)

Screening compound: C<sub>13</sub>H<sub>10</sub>BrClN<sub>2</sub>O<sub>2</sub> (3617-1251)
Screening compound: C<sub>13</sub>H<sub>10</sub>BrClN<sub>2</sub>O<sub>2</sub> (3617-1251) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C13H10BrClN2O2 (3617-1251)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3617-1251

Molecular Formula

C13H10BrClN2O2 (C13 H10 BrClN2 O2)

Compound Name

3-bromo-N-(5-chloropyridin-2-yl)-4-methoxybenzamide

IUPAC name

3-bromo-N-(5-chloropyridin-2-yl)-4-methoxybenzamide

SMILES

COc(ccc(C(Nc(cc1)ncc1Cl)=O)c1)c1Br

InChI

InChI=1S/C13H10BrClN2O2/c1-19-11-4-2-8(6-10(11)14)13(18)17-12-5-3-9(15)7-16-12/h2-7H,1H3,(H,16,17,18)

InChI Key

LVMFYFQGHFZRJN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02218136

C13H10BrClN2O2 (3617-1251) in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

Anti-infective Library (19449 compounds)

Antiviral Annotated Library (21441 compounds)

Human Receptors Annotated Library (5376 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Mechanism of action:
  • Epigenetic
  • Epigenetic
Targets:
  • Kinases
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with C13H10BrClN2O2 (3617-1251) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C13H10BrClN2O2 (3617-1251)?
Check Price and Availability of C13H10BrClN2O2 (3617-1251), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C13H10BrClN2O2 (3617-1251) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C13H10BrClN2O2 (3617-1251)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C13H10BrClN2O2 (3617-1251)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C13H10BrClN2O2 (3617-1251) available by request